BMEA
Biomea Fusion Inc.
Company Overview
| Mkt Cap | $73.27M | Price | $1.36 |
| Volume | 818.24K | Change | +2.26% |
| P/E Ratio | -0.5 | Open | $1.36 |
| Revenue | -- | Prev Close | $1.33 |
| Net Income | $-138.4M | 52W Range | $1.29 - $9.34 |
| Div Yield | N/A | Target | $7.83 |
| Overall | 33 | Value | 60 |
| Quality | 21 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyBiomea Fusion Inc. (BMEA) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $1.36 with a market capitalization of $73.27 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BMEA with a volume of 818K shares. The stock opened up 2.26% from yesterday's close of $1.33. Current analyst estimates project earnings of $-1.49 per share for this year, with next year targeting $-1.4.
BMEA demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for BMEA include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 475.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:03 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMEA | $1.36 | +2.3% | 818.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |